0001225208-15-007464.txt : 20150310
0001225208-15-007464.hdr.sgml : 20150310
20150310175240
ACCESSION NUMBER: 0001225208-15-007464
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20150306
FILED AS OF DATE: 20150310
DATE AS OF CHANGE: 20150310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CIGNA CORP
CENTRAL INDEX KEY: 0000701221
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 061059331
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
BUSINESS PHONE: 8602266000
MAIL ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
FORMER COMPANY:
FORMER CONFORMED NAME: Cigna Corp
DATE OF NAME CHANGE: 20111019
FORMER COMPANY:
FORMER CONFORMED NAME: CIGNA CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manders Matthew G
CENTRAL INDEX KEY: 0001480601
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08323
FILM NUMBER: 15690372
MAIL ADDRESS:
STREET 1: 1601 CHESTNUT STREET
STREET 2: TWO LIBERTY PLACE
CITY: PHILADELPHIA
STATE: PA
ZIP: 19192
4
1
doc4.xml
X0306
4
2015-03-06
0000701221
CIGNA CORP
CI
0001480601
Manders Matthew G
900 COTTAGE GROVE ROAD
BLOOMFIELD
CT
06002
1
Pres. US Comm Mkts & Gbl HC Op
Common Stock, $.25 Par Value
2015-03-06
4
S
0
15263.0000
120.9518
D
50827.0000
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2014.
Represents the weighted average price of the shares sold. The prices actually received ranged from $120.67 to $121.24 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Exhibit List: Exhibit Ex-24 - Power of Attorney, manderspoa.txt
By: Amy Rhoades, attorney-in-fact
2015-03-10
EX-24
2
manderspoa.txt
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned, an officer of Cigna
Corporation, a Delaware corporation ("Cigna"), hereby makes, designates,
constitutes and appoints NICOLE S. JONES, NEIL BOYDEN TANNER, AMY RHOADES, JILL
STADELMAN, and MARGUERITE GEIGER each acting individually, as the
undersigned's true and lawful attorneys-in-fact and agents, with full power and
authority to act in the undersigned's capacity as an officer of Cigna for and in
the name, place and stead of the undersigned in connection with the filing
with the Securities and Exchange Commission pursuant to the Securities Act of
1933 or the Securities Exchange Act of 1934, both as amended, of the execution
and delivery of Forms 3, 4, and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934, Forms 144 in accordance with Rule 144
promulgated under the Securities Act of 1933 and any and all other documents
related thereto (including, but not limited to, Seller's Representation Letters)
and to take further action as they, or any of them, deem appropriate in
connection with the foregoing.
Such attorneys-in-fact and agents, or any of them, are also hereby granted full
power and authority, on behalf of and in the name, place and stead of the
undersigned, to execute and deliver all such amendments, qualifications and
notifications; to execute and deliver any and all such other documents; and to
take further action as they, or any of them, deem appropriate in connection with
the foregoing. The powers and authorities granted herein to such
attorneys-in-fact and agents, and each of them, also include the full right,
power and authority to effect necessary or appropriate substitutions or
revocations.
The undersigned hereby ratifies, confirms, and adopts, as his own act and deed,
all action lawfully taken by such attorneys-in-fact and agents, or any of
them, or by their respective substitutes, pursuant to the powers and authorities
herein granted. This Power of Attorney shall remain in full force and effect
until the undersigned no longer has responsibilities relating to Section 16 of
the Securities Exchange Act of 1934 or Rule 144 promulgated under the Securities
Act of 1933 with respect to the undersigned's beneficial ownership of
securities of Cigna, unless earlier revoked by the undersigned in a signed
writing to each such attorney in fact.
IN WITNESS WHEREOF, the undersigned has executed this document as of
the 5th day of January, 2015.
/s/Matthew G. Manders
Signature
Matthew G. Manders
Print Name